Cannabis-dependence risk relates to synergism between neuroticism and proenkephalin SNPs associated with amygdala gene expression: case-control study.
- Authors
- Jutras-Aswad, Didier; Jacobs, Michelle M; Yiannoulos, Georgia; Roussos, Panos; Bitsios, Panos; Nomura, Yoko; Liu, Xun; Hurd, Yasmin L
- Year
- 2012
- Journal
- PloS one
- PMID
- 22745721
- DOI
- 10.1371/journal.pone.0039243
- PMCID
- PMC3382183
BACKGROUND: Many young people experiment with cannabis, yet only a subgroup progress to dependence suggesting individual differences that could relate to factors such as genetics and behavioral traits. Dopamine receptor D2 (DRD2) and proenkephalin (PENK) genes have been implicated in animal studies with cannabis exposure. Whether polymorphisms of these genes are associated with cannabis dependence and related behavioral traits is unknown. METHODOLOGY/PRINCIPAL FINDINGS: Healthy young adults (18-27 years) with cannabis dependence and without a dependence diagnosis were studied (N = 50/group) in relation to a priori-determined single nucleotide polymorphisms (SNPs) of the DRD2 and PENK genes. Negative affect, Impulsive Risk Taking and Neuroticism-Anxiety temperamental traits, positive and negative reward-learning performance and stop-signal reaction times were examined. The findings replicated the known association between the rs6277 DRD2 SNP and decisions associated with negative reinforcement outcomes. Moreover, PENK variants (rs2576573 and rs2609997) significantly related to Neuroticism and cannabis dependence. Cigarette smoking is common in cannabis users, but it was not associated to PENK SNPs as also validated in another cohort (N = 247 smokers, N = 312 non-smokers). Neuroticism mediated (15.3%-19.5%) the genetic risk to cannabis dependence and interacted with risk SNPs, resulting in a 9-fold increase risk for cannabis dependence. Molecular characterization of the postmortem human brain in a different population revealed an association between PENK SNPs and PENK mRNA expression in the central amygdala nucleus emphasizing the functional relevance of the SNPs in a brain region strongly linked to negative affect. CONCLUSIONS/SIGNIFICANCE: Overall, the findings suggest an important role for Neuroticism as an endophenotype linking PENK polymorphisms to cannabis-dependence vulnerability synergistically amplifying the apparent genetic risk.
DRD2 SNP rs6277 in relation to the accuracy of choose A (positive reinforcement) and Avoid B (negative reinforcement) performance.***, p<0.005 between the genotypes.
Neuroticism scores in relation to PENK rs2609997 SNP among controls, and in cannabis-dependent subjects.*, p<0.05 between the genotypes.
High risk genotype = C/C + C/T for rs2609997 or A/A + A/G for rs2576573; low risk genotype = T/T for rs2609997 or G/G for rs2576573. ***p<0.01; ****p<0.001.
PENK mRNA distribution (A) and expression levels (B) in the amygdala of control subjects with the A/G and G/G genotype for the rs2576573 SNP.Expression levels (mean ± SEM) are denoted as natural log of the DPM/mg values. **p<0.01.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability. | 2018 | 28439100 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Emotional dysregulation, alexithymia and neuroticism: a systematic review on the genetic basis of a subset of psychological traits. | Castellini G et al. | — | 2023 | → |
| Association between Polymorphism rs1799732 of <i>DRD2</i> Dopamine Receptor Gene and Personality Traits among Cannabis Dependency. | Chmielowiec J et al. | — | 2022 | → |
| Neurogenetic and Epigenetic Aspects of Cannabinoids. | Dennen CA et al. | — | 2022 | → |
| Does cannabis use increase anxiety disorders? A literature review. | Shalit N et al. | — | 2020 | → |
| Adolescent Δ<sup>9</sup>-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-κB-Cyclooxygenase-2 Signaling to Impair Memory in Adulthood. | Jouroukhin Y et al. | — | 2019 | → |
| Determining Risks for Cannabis Use Disorder in the Face of Changing Legal Policies. | Taylor M et al. | — | 2019 | → |
| Neurocognitive Precursors of Substance Misuse Corresponding to Risk, Resistance, and Resilience Pathways: Implications for Prevention Science. | Rose EJ et al. | — | 2019 | → |
| Age and impulsive behavior in drug addiction: A review of past research and future directions. | Argyriou E et al. | — | 2018 | → |
| High times for cannabis: Epigenetic imprint and its legacy on brain and behavior. | Szutorisz H et al. | — | 2018 | → |
| Shaping vulnerability to addiction - the contribution of behavior, neural circuits and molecular mechanisms. | Egervari G et al. | — | 2018 | → |
| Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability. | Miller ML et al. | — | 2018 | → |
| A Functional 3'UTR Polymorphism (rs2235749) of Prodynorphin Alters microRNA-365 Binding in Ventral Striatonigral Neurons to Influence Novelty Seeking and Positive Reward Traits. | Egervari G et al. | — | 2016 | → |
| Genetic and Environmental Factors Associated with Cannabis Involvement. | Bogdan R et al. | — | 2016 | → |
| Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families. | Hill SY et al. | — | 2016 | → |
| Association between DRD2/ANKK1 TaqIA polymorphism and common illicit drug dependence: evidence from a meta-analysis. | Deng XD et al. | — | 2015 | → |
| Effects of an opioid (proenkephalin) polymorphism on neural response to errors in health and cocaine use disorder. | Moeller SJ et al. | — | 2015 | → |
| Smoke your troubles away: exploring the effects of death cognitions on cannabis craving and consumption. | Nagar M et al. | — | 2015 | → |
| Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. | Volkow ND et al. | — | 2014 | → |
| Deficits in behavioural inhibition in substance abuse and addiction: a meta-analysis. | Smith JL et al. | — | 2014 | → |
| Dopamine and glucose, obesity, and reward deficiency syndrome. | Blum K et al. | — | 2014 | → |
| Early intervention following trauma may mitigate genetic risk for PTSD in civilians: a pilot prospective emergency department study. | Rothbaum BO et al. | — | 2014 | → |
| Genetic variation in personality traits explains genetic overlap between borderline personality features and substance use disorders. | Few LR et al. | — | 2014 | → |
| Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric. | Blum K et al. | — | 2014 | → |
| The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males. | Koiliari E et al. | — | 2014 | → |
| Trajectory of adolescent cannabis use on addiction vulnerability. | Hurd YL et al. | — | 2014 | → |
| Constraints on decision making: implications from genetics, personality, and addiction. | Baker TE et al. | — | 2013 | → |
| Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. | van der Pol P et al. | — | 2013 | → |